Why Elutia Inc.’s (ELUT) Stock Is Up 5.83%
As of Friday, May 22, Elutia Inc.’s ELUT share price has surged by 5.83%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.
Commentary & Analysis
Why Elutia Inc.’s (ELUT) Stock Is Down 5.89%
As of Thursday, March 05, Elutia Inc.’s ELUT share price has dipped by 5.89%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Elutia Inc.’s (ELUT) Stock Is Up 10.66%
As of Wednesday, March 04, Elutia Inc.’s ELUT share price has surged by 10.66%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Elutia Inc.’s (ELUT) Stock Is Down 5.83%
As of Thursday, February 19, Elutia Inc.’s ELUT share price has dipped by 5.83%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Elutia Inc.’s (ELUT) Stock Is Up 5.07%
As of Wednesday, September 17, Elutia Inc.’s ELUT share price has surged by 5.07%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | ELUT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $35.9 | $259.6 | 13% |
|
| Shares Out (Mil) | 44.2 | 54.2 | 44% |
|
| Institutional Ownership | 79.6% | 93.1% | 48% |
|
| Float (Mil) | 29.5 | 41.4 | 36% |
|
| Beta | 0.88 | 0.95 | 52% |
|
| Avg Daily Volume (000s) | 31 | 675 | 24% |
|
| Price Change (52-week) |
(21.4%) | 51.5% | 34% |
|
| Growth | ELUT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (22.0%) | 13.2% | 2% |
|
| Net Income (5yr) | 34.8% | (10.1%) | 88% |
|
| EPS (5yr) | 16.0% | 15.8% | 60 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (46.6%) | (15.6%) | 8% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ELUT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $12 | $37 | 10% |
|
| Net Income (TTM) (Mil) | $52 | ($44) | 55% |
|
| EPS (TTM) | $1.202 | ($1.600) | 63% |
|
| Operating Cash Flow (TTM) (Mil) | ($44) | ($32) | 10% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $4 | $4 | 23% |
|
| Enterprise Value (Q1) (Mil) | $24 | $174 | 12% |
|
| Valuation | ELUT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.25 | 2.50 | 57% |
|
| P/E | na | 18.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | ELUT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 57.8% | 68.8% | 70% |
|
| Net Margin | 426.9% | (72.5%) | 100% |
|
| ROA | 133.7% | (47.6%) | 100% |
|
| ROE | (397.0%) | (54.6%) | 2% |
|
| Liabilities to Assets | 63.9% | 29.3% | 58% |
|
| F-Score | 5 | 3 | 50% |
|
Elutia Inc. did not pass any screens on 9/28/2026.
